Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Targeted Talks. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Targeted Talks or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

S6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall

14:48
 
Share
 

Manage episode 471231416 series 3293365
Content provided by Targeted Talks. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Targeted Talks or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode of Targeted Talks, Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial (NCT05032820) of idecabtagene vicleucel (ide-cel; Abecma), a study focused on patients with multiple myeloma who had a suboptimal response to first-line therapy, including autologous hematopoietic cell transplant and lenalidomide (Revlimid) maintenance.
  continue reading

71 episodes

Artwork
iconShare
 
Manage episode 471231416 series 3293365
Content provided by Targeted Talks. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Targeted Talks or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode of Targeted Talks, Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial (NCT05032820) of idecabtagene vicleucel (ide-cel; Abecma), a study focused on patients with multiple myeloma who had a suboptimal response to first-line therapy, including autologous hematopoietic cell transplant and lenalidomide (Revlimid) maintenance.
  continue reading

71 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play